Searched for: in-biosketch:yes
person:freids01
Risk reduction among injecting drug users
Chapter by: Des Jarlais, Don C; Friedman, Samuel R
in: AIDS in the world II : global dimensions, social roots, and responses by Mann, Jonathan M; Tarantola, D (Eds)
New York : Oxford University Press, 1996
pp. 264-267
ISBN: 9780195090970
CID: 4848562
USING RETROSPECTIVE BEHAVIORAL-DATA TO DETERMINE HIV RISK FACTORS AMONG STREET-RECRUITED DRUG INJECTORS
DASGUPTA, S; FRIEDMAN, SR; JOSE, B; NEAIGUS, A; ROSENBLUM, A; GOLDSMITH, DS; KLEINMAN, PH; DESJARLAIS, DC
This paper investigates whether the time period during which retrospective behavioral data are collected affects the results of studies of HIV risk factors. In particular, we address the concern that questionnaires probing behaviors in the recent past may not isolate the risk behaviors involved at the time of actual HIV infection. During 1987 and 1988, 278 street-recruited injecting drug users (IDUs) in New York City were interviewed about their sexual behaviors, medical history, drug-injection behaviors in the prior ten years, and specific needle-use behaviors during 1985-86 and thereafter. Among the 278 subjects, 52% were HIV-seropositive. In univariate analysis, serostatus was significantly related to: a) total drug-injection frequency during 1983-84 and 1985-86; b) mean monthly total drug-injection frequency during 1977 to 1987; c)cocaine injection frequencies during 1983-84 and 1985-86, and during the last thirty days, and d) injecting in shooting galleries and using previously used cookers during 1985-86. Significant predictors of seroprevalence in stepwise logistic regression were total drug and cocaine injection frequencies during; 1983-84, years of injection, residence in the Bronx, not being Hispanic and history of any sexually transmitted disease, The data confirm previous reports on behavioral risk factors for HIV serostatus. Re-analysis using drug;injection frequency data for different time periods indicates that in the context of an ''older'' HIV epidemic like that in New York City, analysis of risk factors may be less sensitive to time periods than had previously been feared, although it may be true that data for behaviors in ''the last thirty days'' cover a sufficiently atypical period as to produce misleading results. ISI:A1995QM27800011
ISSN: 0022-0426
CID: 3606442
REDUCED RISK OF HEPATITIS-B AND HEPATITIS-C AMONG INJECTION-DRUG USERS IN THE TACOMA SYRINGE EXCHANGE PROGRAM
HAGAN, H; JARLAIS, DCD; FRIEDMAN, SR; PURCHASE, D; ALTER, MJ
Objectives. This case-control study examined the association between syringe e ISI:A1995TB49300011
ISSN: 0090-0036
CID: 3608962
Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs [Historical Article]
Des Jarlais, D C; Paone, D; Friedman, S R; Peyser, N; Newman, R G
One third of all cases of the acquired immunodeficiency syndrome (AIDS) in the United States are associated with the injection of illicit drugs. There is mounting evidence for the effectiveness of syringe exchange programs in reducing human immunodeficiency virus (HIV) risk behavior and HIV transmission among injection drug users. Expansion of syringe exchange would require increased public funding and undoubtedly would include government regulation of syringe exchanges. An analogy is drawn with the present system of regulation of methadone maintenance treatment programs and possible regulation of syringe exchange programs. Specific recommendations are offered to reduce the likelihood of repeating the regulatory problems of methadone maintenance treatment in future regulation of syringe exchange programs.
PMID: 7485676
ISSN: 0090-0036
CID: 3602402
SYRINGE EXCHANGE PROGRAMS - UNITED-STATES, 1994-1995 (REPRINTED FROM MMWR, VOL 44, PG 684-685, 1995) [Reprint]
PAONE, D; JARLAIS, DCD; CLARK, J; SHI, Q; ORRIS, A; KRIM, M; REINFELD, M; FRIEDMAN, SR; PURCHASE, D; SMITH, H; JONES, P; LURIE, P
ISI:A1995TA10400003
ISSN: 0098-7484
CID: 3608942
Maintaining low HIV seroprevalence in populations of injecting drug users
Des Jarlais, D C; Hagan, H; Friedman, S R; Friedmann, P; Goldberg, D; Frischer, M; Green, S; Tunving, K; Ljungberg, B; Wodak, A
OBJECTIVES: To describe prevention activities and risk behavior in cities where human immunodeficiency virus (HIV) was introduced into the local population of injecting drug users (IDUs), but where seroprevalence has nevertheless remained low (< 5%) during at least 5 years. DESIGN AND SETTING: A literature search identified five such cities: Glasgow, Scotland; Lund, Sweden; Sydney, New South Wales, Australia; Tacoma, Wash; and Toronto, Ontario. Case histories were prepared for each city, including data on prevention activities and current levels of risk behavior among IDUs. PARTICIPANTS: Injecting drug users recruited from both drug treatment and non-treatment settings in each city. INTERVENTIONS: A variety of HIV prevention activities for IDUs had been implemented in each of the five cities. RESULTS: There were three common prevention components present in all five cities: (1) implementation of prevention activities when HIV seroprevalence was still low, (2) provision of sterile injection equipment, and (3) community outreach to IDUs. Moderate levels of risk behavior continued with one third or more of the IDUs reporting recent unsafe injections. CONCLUSIONS: In low-seroprevalence areas, it appears possible to severely limit transmission of HIV among populations of IDUs, despite continuing risk behavior among a substantial proportion of the population. Pending further studies, the common prevention components (beginning early, community outreach, and access to sterile injection equipment) should be implemented wherever populations of IDUs are at risk for rapid spread of HIV.
PMID: 7563513
ISSN: 0098-7484
CID: 171193
Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium
Friedman, S R; Jose, B; Deren, S; Des Jarlais, D C; Neaigus, A
From 1988 to 1991, 6,882 drug injectors in 15 US cities were interviewed and had serum samples collected. The interviews and samples were analyzed for determination of significant predictors of human immunodeficiency virus (HIV) seroconversion in the 10 low seroprevalence cities and the five high seroprevalence cities. The unit of analysis was the period of observation between consecutive paired interviews/blood samples. In Cox proportional hazards regression, significant predictors of seroconversion in the low seroprevalence cities were: not being in drug treatment, injecting in outdoor settings or abandoned buildings, using crack cocaine weekly or more frequently, engaging in woman-to-woman sex, being of non-Latino race/ethnicity, and city seroprevalence. Predictors in high seroprevalence cities were: injecting with potentially infected syringes, not being in drug treatment, and having a sex partner who injected drugs. These findings suggest that HIV may be concentrated in sociobehavioral pockets of infection in low seroprevalence cities. For reducing HIV transmission, these results suggest: 1) in low seroprevalence cities, localized monitoring to detect specific emerging sociobehavioral pockets of infection, and quick implementation of appropriate targeted interventions if necessary; 2) in high seroprevalence cities, relatively more emphasis on locality-wide outreach and syringe-exchange projects to reduce risky behavior; and 3) in both types of cities, considerable expansion of drug treatment programs.
PMID: 7572963
ISSN: 0002-9262
CID: 1577382
Self-reports of HIV risk behavior by injecting drug users: are they reliable?
Goldstein, M F; Friedman, S R; Neaigus, A; Jose, B; Ildefonso, G; Curtis, R
While most studies of AIDS risk behavior rely on self-reports, few studies have assessed the reliability of these reports. The present study examines self-reports of drug-related and sexual risk behavior among pairs of injecting drug users (IDUs) recruited from the streets in New York City. Since both members of the pair were interviewed, it was possible to compare their responses in order to assess reliability. Subjects reported on their contacts' demographic data (age, gender, race/ethnicity) and on shared risk behaviors, including syringe sharing. Despite the private and/or illegal nature of AIDS risk behaviors, IDU subjects were generally reliable in their reports of both demographic and AIDS risk behaviors.
PMID: 7549778
ISSN: 0965-2140
CID: 4842522
HIV/AIDS-related behavior change among injecting drug users in different national settings
Des Jarlais, D C; Friedman, S R; Friedmann, P; Wenston, J; Sotheran, J L; Choopanya, K; Vanichseni, S; Raktham, S; Goldberg, D; Frischer, M
OBJECTIVES/OBJECTIVE:To identify factors associated with effective AIDS behavior change among injecting drug users (IDU) in different national settings. DESIGN/METHODS:Cross-sectional surveys of IDU, with determination of HIV status. Trends in city HIV seroprevalence among IDU also used to validate effectiveness of behavior change. SETTING AND PARTICIPANTS/METHODS:Subjects recruited from drug-use treatment programs and outreach efforts in Bangkok, Thailand (n = 601), Glasgow, Scotland (n = 919), New York City, USA (n = 2539), and Rio de Janeiro, Brazil (n = 466). RESULTS:Evidence for the effectiveness of self-reported risk reduction was available for all cities. Univariate followed by multiple logistic regression analyses were used to identify factors associated with self-reported AIDS behavior change. Separate analyses were conducted for each city. Talking about AIDS with drug-using friends was significantly associated with behavior change in all four cities. Talking with sex partners about AIDS, educational level, knowing that someone can be HIV-infected and still look healthy, and having been tested previously for HIV were each significantly associated with behavior change in three of the four cities. CONCLUSIONS:Despite the substantial differences in these national settings, there were common factors associated with effective risk reduction. In particular, risk reduction appears to occur through social processes rather than through individual attitude change. HIV prevention programs need to explicitly incorporate social processes into their work.
PMID: 7662201
ISSN: 0269-9370
CID: 4240872
Ethical issues in research on preventing HIV infection among injecting drug users
Des Jarlais, Don C; Gaist, Paul A; Friedman, Samuel R
PMID: 11660709
ISSN: 1353-3452
CID: 3601882